- Occupational dermatitis
- Occupational asthma
There are two main occupational illnesses which have been identified by the Health and Safety Authority in Ireland as common diseases caused by a variety of chemical substances found in workplaces across the county.
Occupational dermatitis is a skin disorder which can be caused from coming into contact with certain hazardous substance in the workplace i.e. corrosive, irritating or sensitizing chemical products. Occupational dermatitis manifests itself as an inflammation of the skin which can become red, itchy and cause blistering. In some cases, the skin becomes hard and can thicken and become cracked, causing sores.
As these issues occur when people come in contact with the chemical products, the condition is called contact dermatitis. Contact dermatitis is the most common notified work-related disease in Ireland. It can have long term consequences for workers health and can even affect the ability of employees to complete their work-related tasks.
Determining whether employees are suffered from occupational dermatitis or non-occupational dermatitis can be difficult to determine. However, there are a number of suggestions put forward which can differentiate between the two:
Research has indicted that 10 years after the condition first occurs, up to 50% of affected workers will still have some skin problems.
Asthma is an inflammatory disorder of the airways. Occupational asthma is asthma which is caused by breathing in chemical dusts, fumes, vapours and/or other substances in the workplace. Asthma related to the workplace are divided into two different categories:
This is developed by persons with a history of pre-existing asthma. These people may get wheezy or have other symptoms at work when exposed to specific chemicals. The problem can often be eliminated by improving the work environment, introducing ventilation or avoiding the irritant altogether.
Caused as a direct result of workplace exposure. There are 2 forms of occupational asthma:
Work related asthma accounts for 10% of all adult onset asthma.